107 related articles for article (PubMed ID: 35730383)
1. Neurodevelopmental outcomes of HIV/antiretroviral drug perinatally exposed uninfected children aged 3-6 years.
Fowler MG; Hanrahan C; Yende N; Stranix-Chibanda L; Chipato T; Maliwichi L; Gadama L; Aizire J; Dadabhai S; Chinula L; Wambuzi-Owang L; Owor M; Violari A; Nyati M; Hanley S; Govender V; Brummel S; Taha T
AIDS; 2022 Sep; 36(11):1533-1543. PubMed ID: 35730383
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.
Boivin MJ; Barlow-Mosha L; Chernoff MC; Laughton B; Zimmer B; Joyce C; Bwakura-Dangarembizi M; Ratswana M; Abrahams N; Fairlie L; Gous H; Kamthunzi P; McCarthy K; Familiar-Lopez I; Jean-Phillippe P; Coetzee J; Violari A; Cotton MF; Palumbo PE;
AIDS; 2018 Jan; 32(2):189-204. PubMed ID: 29112069
[TBL] [Abstract][Full Text] [Related]
4. African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus.
Boivin MJ; Chernoff M; Fairlie L; Laughton B; Zimmer B; Joyce C; Barlow-Mosha L; Bwakura-Dangarembizi M; Vhembo T; Ratswana M; Kamthunzi P; McCarthy K; Familiar-Lopez I; Jean-Philippe P; Coetzee J; Abrahams N; Gous H; Violari A; Cotton MF; Palumbo PE
Clin Infect Dis; 2020 Oct; 71(7):e105-e114. PubMed ID: 31848582
[TBL] [Abstract][Full Text] [Related]
5. Neurocognitive testing in West African children 3-6 years of age: Challenges and implications for data analyses.
Bodeau-Livinec F; Davidson LL; Zoumenou R; Massougbodji A; Cot M; Boivin MJ
Brain Res Bull; 2019 Feb; 145():129-135. PubMed ID: 29630997
[TBL] [Abstract][Full Text] [Related]
6. Neruodevelopmental Outcomes in Preschool Children Living With HIV-1 Subtypes A and D in Uganda.
Ruiseñor-Escudero H; Sikorskii A; Familiar-Lopez I; Persaud D; Ziemniak C; Nakasujja N; Opoka R; Boivin M
Pediatr Infect Dis J; 2018 Dec; 37(12):e298-e303. PubMed ID: 29746376
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Association between caregiver depression symptoms and child executive functioning. Results from an observational study carried out in four sub-Saharan countries.
Familiar I; Chernoff M; Ruisenor-Escudero H; Laughton B; Joyce C; Fairlie L; Vhembo T; Kamthunzi P; Barlow-Barlow L; Zimmer B; McCarthy K; Boivin MJ
AIDS Care; 2020 Apr; 32(4):486-494. PubMed ID: 31462095
[TBL] [Abstract][Full Text] [Related]
9. Low risk of neurodevelopmental impairment among perinatally acquired HIV-infected preschool children who received early antiretroviral treatment in Thailand.
Jantarabenjakul W; Chonchaiya W; Puthanakit T; Theerawit T; Payapanon J; Sophonphan J; Veeravigom M; Jahanshad N; Thompson PM; Ananworanich J; Malee K; Pancharoen C;
J Int AIDS Soc; 2019 Apr; 22(4):e25278. PubMed ID: 30990969
[TBL] [Abstract][Full Text] [Related]
10. Decreased growth among antiretroviral drug and HIV-exposed uninfected versus unexposed children in Malawi and Uganda.
Aizire J; Sikorskii A; Ogwang LW; Kawalazira R; Mutebe A; Familiar-Lopez I; Mallewa M; Taha T; Boivin MJ; Fowler MG;
AIDS; 2020 Feb; 34(2):215-225. PubMed ID: 31634154
[TBL] [Abstract][Full Text] [Related]
11. Language outcomes of preschool children who are HIV-exposed uninfected: An analysis of a South African cohort.
Green F; du Plooy C; Rehman AM; Nhapi RT; Lake MT; Barnett W; Hoffman N; Zar HJ; Donald KA; Stein DJ; Wedderburn CJ
PLoS One; 2024; 19(4):e0297471. PubMed ID: 38598467
[TBL] [Abstract][Full Text] [Related]
12. The multi-country PROMOTE HIV antiretroviral treatment observational cohort in Sub-Saharan Africa: Objectives, design, and baseline findings.
Taha TE; Yende-Zuma N; Aizire J; Chipato T; Wambuzi Ogwang L; Makanani B; Chinula L; Nyati MM; Hanley S; Brummel SS; Fowler MG
PLoS One; 2018; 13(12):e0208805. PubMed ID: 30543692
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental outcomes in HIV-infected and uninfected African children.
Debeaudrap P; Bodeau-Livinec F; Pasquier E; Germanaud D; Ndiang ST; Nlend AN; Ndongo FA; Guemkam G; Penda CI; Warszawski J; Koecher D; Faye A; Tejiokem MC;
AIDS; 2018 Nov; 32(18):2749-2757. PubMed ID: 30289800
[TBL] [Abstract][Full Text] [Related]
14. The development of children born to young mothers with no, first- or second-generation HIV acquisition in the Eastern Cape province, South Africa: a cross-sectional study.
Sherr L; Haag K; Steventon Roberts KJ; Cluver LD; Wittesaele C; Saliwe B; Tolmay J; Langwenya N; Jochim J; Saal W; Zhou S; Marlow M; Chen-Charles JJ; Toska E
BMJ Open; 2022 Oct; 12(10):e058340. PubMed ID: 36229140
[TBL] [Abstract][Full Text] [Related]
15. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
16. Nutritional and Immunological Correlates of Memory and Neurocognitive Development Among HIV-Infected Children Living in Kayunga, Uganda.
Ruiseñor-Escudero H; Familiar-Lopez I; Sikorskii A; Jambulingam N; Nakasujja N; Opoka R; Bass J; Boivin M
J Acquir Immune Defic Syndr; 2016 Apr; 71(5):522-9. PubMed ID: 26605506
[TBL] [Abstract][Full Text] [Related]
17. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
[TBL] [Abstract][Full Text] [Related]
18. Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School-Aged Children.
Brahmbhatt H; Boivin M; Ssempijja V; Kagaayi J; Kigozi G; Serwadda D; Violari A; Gray RH
J Acquir Immune Defic Syndr; 2017 May; 75(1):1-8. PubMed ID: 28169874
[TBL] [Abstract][Full Text] [Related]
19. Cross-cultural assessment of HIV-associated cognitive impairment using the Kaufman assessment battery for children: a systematic review.
van Wyhe KS; van de Water T; Boivin MJ; Cotton MF; Thomas KG
J Int AIDS Soc; 2017 Jun; 20(1):21412. PubMed ID: 28664684
[TBL] [Abstract][Full Text] [Related]
20. Quality of Caregiving is Positively Associated With Neurodevelopment During the First Year of Life Among HIV-Exposed Uninfected Children in Uganda.
Familiar I; Collins SM; Sikorskii A; Ruisenor-Escudero H; Natamba B; Bangirana P; Widen EM; Achidri D; Achola H; Onen D; Boivin M; Young SL
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):235-242. PubMed ID: 29210832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
